HIPRA Human Health

HIPRA is a Spanish pharmaceutical company that has expanded its expertise from veterinary medicine into the human health sector, specifically focusing on vaccine development. The company's flagship human health product is Bimervax, a recombinant protein-based COVID-19 vaccine that received European Commission authorization as a booster dose. HIPRA utilizes a sophisticated recombinant protein platform that allows for the rapid adaptation of vaccines to new viral variants. With a strong emphasis on research and development, the company operates extensive manufacturing facilities in Spain to ensure global supply. HIPRA's entry into human health represents a strategic pivot to leverage its decades of experience in immunology and biotechnology.